I picked up a few shares in the fours. Like was said here I think this could be a booming company if they get their costs under control and revenue up. The new CEO seems to be more attuned to these realities. I'm banking on an increase in this NSF technology given Give the transmission problems covid has brought up. At this point it won't be till next quarter before we see any realistic movement, Although there was an announcement of a partnership that seems promising. When I'm done with BRAV I'll probly think a chunk it here. Hopefully more investor traffic will come here.
News 
Market Data 
Discover 
